Personal Capital Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$539K Sell
3,977
-275
-6% -$34.5K ﹤0.01% 291
2022
Q3
$466K Buy
4,252
+496
+13% +$62.9K ﹤0.01% 293
2022
Q2
$496K Buy
3,756
+5
+0.1% +$656 ﹤0.01% 276
2022
Q1
$498K Sell
3,751
-663
-15% -$79.5K ﹤0.01% 307
2021
Q4
$500K Buy
4,414
+570
+15% +$67.1K ﹤0.01% 334
2021
Q3
$462K Sell
3,844
-146
-4% -$17K ﹤0.01% 322
2021
Q2
$478K Sell
3,990
-704
-15% -$77.2K ﹤0.01% 315
2021
Q1
$467K Sell
4,694
-881
-16% -$88.6K ﹤0.01% 316
2020
Q4
$557K Buy
5,575
+121
+2% +$12.8K ﹤0.01% 288
2020
Q3
$598K Buy
5,454
+130
+2% +$14.5K ﹤0.01% 269
2020
Q2
$563K Sell
5,324
-598
-10% -$61.8K ﹤0.01% 246
2020
Q1
$529K Buy
5,922
+1,603
+37% +$151K 0.01% 252
2019
Q4
$431K Buy
4,319
+999
+30% +$94.1K ﹤0.01% 279
2019
Q3
$295K Buy
+3,320
New +$288K ﹤0.01% 295

Other funds holding AZN